Peng Men

Affiliations
  • Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China.
  • Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China.
ORCID: http://orcid.org/0000-0003-4429-3792

Publications (3)

Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost-Utility Analysis.

Diabetes therapy : research, treatment and education of diabetes and related disorders
Avec: Peng Men , Shuli Qu , Zhenqiang Song , Yanjun Liu , Chaoyun Li , Suodi Zhai

Comparison of lixisenatide in combination with basal insulin vs other insulin regimens for the treatment of patients with type 2 diabetes inadequately controlled by basal insulin: Systematic review, network meta-analysis and cost-effectiveness analysis.

Diabetes, obesity & metabolism
Avec: Peng Men , Shuli Qu , Wenting Luo , Chaoyun Li , Suodi Zhai

The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Avec: S Su , N He , P Men , C Song , S Zhai

Réseau de co-auteurs

Shuli Qu 2 collaborations
Chaoyun Li 2 collaborations
Suodi Zhai 2 collaborations
Zhenqiang Song 1 collaboration
Yanjun Liu 1 collaboration
Wenting Luo 1 collaboration
S Su 1 collaboration
N He 1 collaboration
P Men 1 collaboration
C Song 1 collaboration
S Zhai 1 collaboration